PTC THERAPEUTICS
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
PTC THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
1998-01-01
Address:
South Plainfield, New Jersey, United States
Country:
United States
Website Url:
http://www.ptcbio.com
Total Employee:
101+
Status:
Active
Contact:
9082227231
Email Addresses:
[email protected]
Total Funding:
568.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-05-06 | Censa Pharmaceuticals | Censa Pharmaceuticals acquired by PTC Therapeutics | N/A |
| 2019-10-25 | BioElectron Technology Corporation | BioElectron Technology Corporation acquired by PTC Therapeutics | 210 M USD |
| 2018-07-19 | Agilis Biotherapeutics | Agilis Biotherapeutics acquired by PTC Therapeutics | 200 M USD |
Investors List
Jennison Associates
Jennison Associates investment in Private Equity Round - PTC Therapeutics
Vulcan Capital
Vulcan Capital investment in Private Equity Round - PTC Therapeutics
Adage Capital Management
Adage Capital Management investment in Private Equity Round - PTC Therapeutics
Delphi Ventures
Delphi Ventures investment in Private Equity Round - PTC Therapeutics
Brookside Capital
Brookside Capital investment in Private Equity Round - PTC Therapeutics
Novo Holdings
Novo Holdings investment in Private Equity Round - PTC Therapeutics
Longwood Fund
Longwood Fund investment in Private Equity Round - PTC Therapeutics
Credit Suisse
Credit Suisse investment in Private Equity Round - PTC Therapeutics
Novo Holdings
Novo Holdings investment in Private Equity Round - PTC Therapeutics
Credit Suisse
Credit Suisse investment in Private Equity Round - PTC Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-01-13 | ClearPoint Neuro | PTC Therapeutics investment in Post-IPO Equity - ClearPoint Neuro | 17.5 M USD |
Newest Events participated
Participated in OrphanDrug Congress USA 2017
on 2017-04-19 as sponsor
Participated in The Conference of Things Manufacturing
on 2015-11-26 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-17 | PTC Therapeutics elevates biotech buyout CEO to chief development officer |
Official Site Inspections
http://www.ptcbio.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.46 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PTC Therapeutics"
About PTC Therapeutics - Treatments for Rare Diseases
PTC is committed to providing access to best-in-class treatments for patients with little to no treatment options. This mission underpins our focus on the discovery, development, and global commercialization of clinically differentiated …See details»
PTC Therapeutics - Meet our Leadership Team
The executive leadership team at PTC Therapeutics is a profoundly inspiring group of innovators working toward a brighter future for rare disease treatments.See details»
PTC Therapeutics - Wikipedia
40°33′03″N 74°25′23″W / 40.550722°N 74.423071°W PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases. See details»
PTC Therapeutics Enters into a Global License and Collaboration ...
6 days ago PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn …See details»
PTC Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 9082227231 PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization …See details»
PTC Therapeutics, Inc. | LinkedIn
PTC Therapeutics, Inc. | 71,510 followers on LinkedIn. We're committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones. | PTC is a patient ...See details»
Release Details - PTC Therapeutics, Inc.
Jun 21, 2023 PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn …See details»
Stuart Peltz, Ph.D., Rare Disease Pioneer, to Retire as Chief …
Mar 24, 2023 To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on Twitter at @PTCBio, and on LinkedIn. For More Information: Investors: Kylie …See details»
PTC Celebrates 10 Years of Impact in Europe
Jun 4, 2024 “Our enriched culture of innovation and entrepreneurship has been key to PTC’s success in Europe and globally. As we have grown from just a few employees in 2014 to a more diverse +180 people workforce in the region now …See details»
MEDhub Home - Latest scientific data and expert insights
Jan 17, 2024 This website is organized and funded by PTC Therapeutics for healthcare professionals only. For medical inquiries get in touch at [email protected] This website may include scientific information about …See details»
PTC Therapeutics Enters into a Global License and Collaboration ...
6 days ago - PTC to receive $1.0B in cash at closing - - PTC is eligible to receive up to $1.9B in development, regulatory and sales milestones - - PTC to share profits in the U.S. and tiered …See details»
PTC’S GENE THERAPY CENTER OF EXCELLENCE - PTC Therapeutics
Oct 5, 2021 To learn more, send an email to: [email protected] 220,000 square foot state-of-the-art research and biologics facility to support gene therapy production …See details»
PTC Therapeutics Provides Corporate Update and Highlights …
Jan 13, 2020 Corporate Highlights: Gene Therapy Platform Update: PTC has submitted a Marketing Authorization Application (MAA) for the potential approval of a gene therapy …See details»
PTC Therapeutics - Responsibilities and Global Initiatives
We work hard to provide resources and support to patients and their families through compassionate collaboration, throughout the drug development process. We strive to ensure …See details»
PTC THERAPEUTICS’ APPROACH TO GENE THERAPY
Gene therapy holds tremendous promise . for some of the most debilitating and intractable rare, genetic disorders. PTC is at the forefront of a new and transformativeSee details»
PTC Therapeutics - The Complete History of PTC Since 1998
PTC Therapeutics was founded in 1998 focused on leveraging its expertise in RNA biology to discover and develop treatments for patients living with rare diseases.See details»
PTC Therapeutics Announces FDA Approval of AADC Deficiency …
Nov 13, 2024 PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, …See details»
From Lab to Patient - PTC Therapeutics
Abbreviations AADC, Aromatic L-amino acid decarboxylase; HCP, Healthcare professional; 3-OMD, 3-O-methyldopa References 1. National Human Genome Research Institute ...See details»
A Whole Team in One Molecule: PTC’s Splicing Platform
Dec 18, 2023 The PTC research team has also applied the splicing platform to Huntington’s disease (HD) for a potential treatment for HD called PTC518. HD is a rare disease caused by …See details»